20140122 HL7 PLA Meeting

return to HL7 Product Line Architecture Meeting Minutes and Agendas
Return to HL7 Product Line Architecture Program

HL7 PLA Call Minutes Location: Room TBD		Date: 2014-01-22 Time: 1:45 PM Central (Q3)
Facilitator	Austin Kreisler	Note taker(s)	Lynn

Attendee	Name
	Calvin Beebe
	Woody Beeler
	Lorraine Constable
	Jane Curry
	Bo Dagnall
	Jean Duteau,
	Tony Julian
	Paul Knapp
	Austin Kreisler,
	Lynn Laakso
	Don Lloyd
	Ken McCaslin
	Ron Parker
	Brian Pech
	John Quinn
no quorum definition

Agenda

Agenda review

• Notes of 20131211 PLA call review
• Map our existing products into notional division of products into product families and lines, to provide examples for peer review.
  • Level of granularity
  • Identify which pieces are orphaned, and the political elements to be surfaced.
  • Positioning cross-product family artifacts (standards naming)
• BAM-lite feedback and review
  • Governance on V2.x (v2.9 substantive changes)
  • develop form to request establishing a Product Family

Minutes

Agenda review - Ken had discussed with Austin that we need to review everything under standards on the website and categorize them into preliminary concepts of product families and lines in order to figure out how to move forward.

• Map our existing products into notional division of products into product families and lines, to provide examples for peer review.
  • Is certification a product? Is it something that is an artifact that allows you to achieve interoperability.
  • Outward facing collection of items for consumability is product line. Coherent collection from a consumability perspective is product line.
  • FHIR architecture is a product family - Production perspective.

Product Family

• FHIR
• V2
• V3
• vMR-CDS
• EHR-S FM
• Arden Syntax
• CCOW
• GELLO
• DAM? Are they a product family? With the ArB definition should share common method of production. Analytical viewpoint from where requirements are derived. Most DAMs also have use cases in them. What do we call them - "Analysis Artifacts"? Methodology ans structure for how they are produced is coherent. It is at a higher level on the ECCF than other products.
• Templates? are structures in V2 considered a template? V3 has templates mechanism being defined, CDA also has structured data templates. It is intended to feed into reuse, constraint or extensibility.
• Conformance and certification - conformance assertions skillset and methodology should be consistent across paradigms. Ron notes that some WGs may have to reframe thinking the application of methodology.
  • Certification is individual conformance to HL7's established standards of performance notes Ken. Ron agrees that certification is adherence to standards of conformance. John suggests you might regard it as managing optionality.

Product Family
Product Line	FHIR	V3	V2	DAM	CDA
?		RIM			C-CDA
e.g.	C-CDA		C-CDA
Lab		LRI IG LOI IG eDOS IG	LAB DAM	C-CDA
S&I/MU US Realm		LRI IG LOI IG eDOS IG		C-CDA

Meeting Outcomes

Actions

Next Meeting/Preliminary Agenda Items TBD

© 2014 Health Level Seven® International. All rights reserved